Brief: Poseida Therapeutics To Present Preclinical Data Of Fully Allogeneic CAR-T Product Candidates

Poseida Therapeutics

09/11/2021 13:10

Nov 9 (Reuters) - Poseida Therapeutics Inc  PSTX.O :
    * POSEIDA THERAPEUTICS TO PRESENT PRECLINICAL DATA
HIGHLIGHTING
FULLY ALLOGENEIC CAR-T PRODUCT CANDIDATES AT THE SOCIETY FOR
IMMUNOTHERAPY OF CANCER 2021 ANNUAL MEETING

Source text for Eikon:  ID:nPn5S6CLZa 
Further company coverage:  PSTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))